Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the-Counter Human Use
---
identifier: "/us/fr/C1-2011-14766"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the-Counter Human Use"
title_number: 0
title_name: "Federal Register"
section_number: "C1-2011-14766"
section_name: "Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the-Counter Human Use"
positive_law: false
currency: "2011-07-05"
last_updated: "2011-07-05"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "C1-2011-14766"
document_type: "rule"
publication_date: "2011-07-05"
agencies:
- "Health and Human Services Department"
- "Food and Drug Administration"
cfr_references:
- "21 CFR Part 201"
rin: "0910-AF43"
fr_citation: "76 FR 38975"
fr_volume: 76
docket_ids:
- "Docket No. FDA-1978-N-0018"
---
# [Corrected]
**Correction**
In rule document 2011-14766 appearing on pages 35620-35665 in the issue of Friday, June 17, 2011, make the following correction:
**21 CFR Part 201**
§ 201.327
In § 201.327, on page 35661, in the third column, § 201.327(i)(1)(ii)(A)( *2* ) and ( *3* ) should read as follows:
( *2* ) V <sub>i</sub> (λ) = 10 <sup>0.094</sup><sub>* (</sub><sup>298</sup>*-λ)* (298 < λ ≤ 328 nm)
( *3* ) V <sub>i</sub> (λ) = 10 <sup>0.015</sup><sub>* (</sub><sup>140</sup>*-λ)* (328 < λ ≤ 400 nm)